Cardiome Pharma Corp. (USA) (NASDAQ:CRME)

CAPS Rating: 3 out of 5

Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.

Results 21 - 28 of 28 : « Previous 1 2

Recs

0
Member Avatar bjova (26.98) Submitted: 12/13/2007 6:34:51 PM : Outperform Start Price: $8.75 CRME Score: -88.53

It gets a 6-2 vote in favor and sells off. I don't really understand, but think that it will head back into the double digits...

Recs

0
Member Avatar dalenvic (< 20) Submitted: 9/6/2007 9:33:14 PM : Outperform Start Price: $8.65 CRME Score: -89.85

Clinical studies very positive for conversion of Atrial
Fibrillation. Side-effect profile benign. Currently with
intravenous formulation, awaiting oral clinical studies.
Very lucrative upside if recommended by FDA
committee in January.

Recs

0
Member Avatar toocrazy (< 20) Submitted: 8/29/2007 4:31:47 PM : Outperform Start Price: $8.80 CRME Score: -90.60

It would be hard to go against what all have said, dark horse, speculative, takeover candidate, needs successful clinical trials, reasonable entry point.

Put your money down and roll.....

Recs

0
Member Avatar Wrigleyky (76.18) Submitted: 7/17/2007 9:46:16 PM : Outperform Start Price: $9.80 CRME Score: -85.67

Speculative play in biotech

Recs

0
Member Avatar pSH51 (< 20) Submitted: 7/13/2007 9:56:58 AM : Outperform Start Price: $9.94 CRME Score: -85.57

dark horse with great buy in price...

Recs

0
Member Avatar vr862 (53.65) Submitted: 5/30/2007 11:10:58 AM : Underperform Start Price: $9.63 CRME Score: +87.38

Poor company in the sector.

Recs

0
Member Avatar ENCY (< 20) Submitted: 4/13/2007 4:09:09 PM : Outperform Start Price: $10.32 CRME Score: -91.50

IV agent for atrial fib is best in class and will be approved. Oral agent has great promise

Recs

0
Member Avatar EhglandN95 (< 20) Submitted: 10/22/2006 11:48:22 AM : Outperform Start Price: $10.62 CRME Score: -98.53

Successful clinical trials with new drug to treat atrial fibrillation. May be a takeover candidate.

Results 21 - 28 of 28 : « Previous 1 2

Featured Broker Partners


Advertisement